RECRUITING

Corticosteroid Injection Versus Nerve Block

Description

The purpose of this study is to evaluate conservative pain relief measures for patients suffering from glenohumeral arthritis or rotator cuff arthropathy. Conservative management of osteoarthritis is often first line treatment, and while a corticosteroid injection is frequently used, suprascapular nerve blocks have not often been described as an analgesic option in this population.

Study Overview

Study Details

Study overview

The purpose of this study is to evaluate conservative pain relief measures for patients suffering from glenohumeral arthritis or rotator cuff arthropathy. Conservative management of osteoarthritis is often first line treatment, and while a corticosteroid injection is frequently used, suprascapular nerve blocks have not often been described as an analgesic option in this population.

A Randomized Comparative Cohort Study of the Use of Intra-articular Corticosteroid Injection Compared to Suprascapular Nerve Block for Treatment of Shoulder Pain

Corticosteroid Injection Versus Nerve Block

Condition
Glenohumeral Arthritis
Intervention / Treatment

-

Contacts and Locations

Minneapolis

University of Minnesota, Minneapolis, Minnesota, United States, 55414

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * diagnosis of glenohumeral osteoarthritis, rheumatoid arthritis, or rotator cuff arthropathy who are being offered injection
  • * uncontrolled diabetes (patients will be excluded if no HbA1c within a year or if it is 8 or greater"
  • * known allergy to steroid or anesthetic
  • * pregnant women
  • * prisoners
  • * patients with diminished capacity to consent to participation
  • * children under 18 years of age
  • * non-English speakers

Ages Eligible for Study

18 Years to 99 Years

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

University of Minnesota,

Allison Rao, MD, PRINCIPAL_INVESTIGATOR, University of Minnesota

Study Record Dates

2026-01-02